Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.
about
Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer CellsRab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans.Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.Roles of LPA receptor signaling in breast cancer.
P2860
Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Aberrant expression and potent ...... riple-negative breast cancers.
@ast
Aberrant expression and potent ...... riple-negative breast cancers.
@en
type
label
Aberrant expression and potent ...... riple-negative breast cancers.
@ast
Aberrant expression and potent ...... riple-negative breast cancers.
@en
prefLabel
Aberrant expression and potent ...... riple-negative breast cancers.
@ast
Aberrant expression and potent ...... riple-negative breast cancers.
@en
P2093
P2860
P1476
Aberrant expression and potent ...... riple-negative breast cancers.
@en
P2093
Jiansheng Wang
Jingkun Qu
Xiaoyi Duan
P2860
P2888
P304
P356
10.1007/S10238-014-0306-5
P577
2014-09-11T00:00:00Z